ZEVRA THERAPEUTICS INC. - COMMON STOCK

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

08 1月 2026 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

29 12月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

12 12月 2025 16:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD

02 12月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics, Inc. Announces CFO Transition

20 11月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update

05 11月 2025 16:05:02 条件 Nasdaq GlobeNewswire

Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference

29 10月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call

27 10月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 10月 2025 17:51:06 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate)

18 9月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)

04 9月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM)

28 8月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics to Participate at Upcoming Investor Conferences in September

26 8月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Reports Second Quarter 2025 Financial Results and Corporate Update

12 8月 2025 16:05:19 条件 Nasdaq GlobeNewswire

Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference

06 8月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call

04 8月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

28 7月 2025 06:00:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)

18 7月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism

16 7月 2025 07:30:00 条件 Nasdaq GlobeNewswire

Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference

11 7月 2025 07:30:00 条件 Nasdaq GlobeNewswire